Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Liver transplantation

• Publication date

  2002-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1053/jlts.2002.32282PMID 11965581
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Progression of liver fibrosis in patients with chronic hepatitis C after orthotopic liver transplantation

  2003cited by this paper
• Genotype 1b and severity of posttransplant recurrence of hepatitis C infection— unconvictable felon or wrongly accused?

  2000cited by this paper
• THE INFLUENCE OF CYTOMEGALOVIRUS VIRAEMIA ON THE OUTCOME OF RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION12

  2000cited by this paper
• An association between cytomegalovirus infection and chronic rejection after liver transplantation.

  2000cited by this paper
• HCV-related fibrosis progression following liver transplantation: increase in recent years.

  2000cited by this paper
• The economic impact of cytomegalovirus infection after liver transplantation.

  2000cited by this paper
• Management of cytomegalovirus infection after liver transplantation

  2000cited by this paper
• Hepatitis C and liver transplantation

  1999cited by this paper
• Recurrence of hepatitis C virus infection after liver transplantation.

  1999cited by this paper
• Preoperative hepatic artery chemoembolization followed by orthotopic liver transplantation for hepatocellular carcinoma.

  1999cited by this paper
• Hepatitis C virus recurrence after liver transplantation

  1999cited by this paper
• Impact of immunosuppression and acute rejection on recurrence of hepatitis C: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database.

  1999cited by this paper
• Comparison of pharmacokinetics of Neoral and Sandimmune in stable pediatric liver transplant recipients.

  1999cited by this paper
• The outcome of hepatitis C virus infection after liver transplantation--is it influenced by the type of immunosuppression?

  1999cited by this paper
• A long-term comparison of tacrolimus (FK506) versus cyclosporine in liver transplantation: a report of the United States FK506 Study Group.

  1998cited by this paper
• Predictors of patient and graft survival following liver transplantation for hepatitis C

  1998cited by this paper
• Clinical significance of viral load in the diagnosis of cytomegalovirus disease after liver transplantation.

  1998cited by this paper
• Multigene Tracking of Hepatitis C Virus Quasispecies after Liver Transplantation: Correlation of Genetic Diversification in the Envelope Region with Asymptomatic or Mild Disease Patterns

  1998cited by this paper
• Relationship between hepatitis C genotype and severity of recurrent hepatitis C after liver transplantation.

  1997cited by this paper
• Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation.

  1997cited by this paper
• Cytomegalovirus viremia: risk factor for allograft cirrhosis after liver transplantation for hepatitis C.

  1997cited by this paper
• Prophylaxis of cytomegalovirus infection in liver transplantation: a randomized trial comparing a combination of ganciclovir and acyclovir to acyclovir. NIDDK Liver Transplantation Database.

  1997cited by this paper
• Cytomegalovirus prophylaxis in solid organ transplant recipients.

  1996cited by this paper
• Histological grading and staging of chronic hepatitis.

  1995cited by this paper
• OKT3 treatment for allograft rejection is a risk factor for cytomegalovirus disease in liver transplantation.

  1995cited by this paper
• A prospective comparison of molecular diagnostic techniques for the early detection of cytomegalovirus in liver transplant recipients.

  1995cited by this paper
• Severe or multiple rejection episodes are associated with early recurrence of hepatitis C after orthotopic liver transplantation

  1995cited by this paper
• Histological grading and staging of chronic hepatitis.

  1995cited by this paper
• Chronic hepatitis. An update on terminology and reporting.

  1995cited by this paper
• A proposed system for the nomenclature of hepatitis C viral genotypes

  1994cited by this paper
• Advances in the diagnosis, treatment, and prevention of cytomegalovirus infections after liver transplantation.

  1993cited by this paper
• Cytomegalovirus infection and disease after liver transplantation

  1992cited by this paper

• Hepatotropic and Nonhepatotropic Viral Infection in Liver Transplant Recipients

  2025cites this paper
• Impact of Donor CMV‐Seropostive Grafts on Prognosis of Liver Transplantation for Hepatocellular Carcinoma

  2025cites this paper
• Epidemiology and pathogen characteristics of infections following solid organ transplantation.

  2024cites this paper
• Impact of Donation After Circulatory Death Allografts on Outcomes After Liver Transplant for Hepatitis C: A Single-Center Experience and Review of the Literature.

  2022cites this paper
• Outcomes of Adult Liver Retransplantation: A Canadian National Database Analysis

  2022cites this paper
• "Safe use of livers from deceased donors older than 70 years in recipients with HCV cirrhosis treated with direct-action antivirals. Retrospective cohort study".

  2021cites this paper
• Liver Transplantation and HCV Genotype 4

  2021cites this paper
• Hepatitis A and Other Viral Infections

  2020cites this paper
• Cytomegalovirus and Epstein-Barr Virus Infection and Disease

  2019cites this paper
• Serp-2, a virus-derived apoptosis and inflammasome inhibitor, attenuates liver ischemia-reperfusion injury in mice

  2019cites this paper
• ESITRA-SEIMC / REIPI recommendations for the management of cytomegalovirus nfection in solid-organ transplant patients

  2019cites this paper
• Reduction in mortality associated with secondary cytomegalovirus prophylaxis after solid organ transplantation

  2018cites this paper
• Cytomegalovirus reactivation in liver transplant recipients due to hepatitis C cirrhosis is associated with higher cardiovascular risk – an observational, retrospective study

  2018cites this paper
• Live donor liver transplantation with older donors: Increased long‐term graft loss due to HCV recurrence

  2018cites this paper
• Hepatic Transplantation and HBV, HCV, and HIV Infections

  2018cites this paper
• A survey of the frequency of cytomegalovirus-associated diarrhea in immunocompromised patients using a non-invasive method

  2018cites this paper
• Incidence and Predictors of Advanced Liver Fibrosis by a Validated Serum Biomarker in Liver Transplant Recipients

  2017cites this paper
• 82 – Liver Transplantation

  2017cites this paper
• Cytomegalovirus Infection among Patients with Chronic Hepatitis C Virus and its relation to hepatitis C virus load

  2017cites this paper
• Cytomegalovirus Infection in Liver Transplant Recipients: Current Approach to Diagnosis and Management.

  2017cites this paper
• Cytomegalovirus in liver transplant recipients

  2017cites this paper
• Management of cytomegalovirus infection in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations.

  2016cites this paper
• XXXIII CONGRESO NACIONAL DE LA ASOCIACIÓN ESPAÑOLA PARA EL ESTUDIO DEL HÍGADO

  2016cites this paper
• Impact of Cytomegalovirus Infection on Severe Hepatitis C Recurrence in Patients Undergoing Liver Transplantation

  2016cites this paper
•  Good outcomes of liver transplantation for hepatitis C at a low volume centre.

  2016cites this paper
• PROBLEMAS DURANTE EL PERÍODO PERIOPERATORIO DEL TRASPLANTE HEPÁTICO: PROFILAXIS Y TRATAMIENTO

  2016cites this paper
• Eficacia y seguridad de Ganciclovir y Valganciclovir en el manejo de la infección por citomegalovirus en el trasplante de órgano sólido

  2016cites this paper
• Cytomegalovirus infection after solid organ transplantation

  2016cites this paper
• New modalities in the treatment of HCV in pre and post - transplantation setting.

  2015cites this paper
• Analysis of Post-Liver Transplant Hepatitis C Virus Recurrence Using Serial Cluster of Differentiation Antibody Microarrays

  2015cites this paper
• Chapter 79 – Recurrent Hepatitis C After Transplantation

  2015cites this paper
• Management of Hepatitis C Post-liver Transplantation: a Comprehensive Review

  2015cites this paper
• Liver Immunology: Principles and Practice

  2015cites this paper
• CMV and transfusions, an old story that's not quite over yet

  2014cites this paper
• Hepatitis C virus molecular evolution: transmission, disease progression and antiviral therapy.

  2014cites this paper
• Predictors of Disease Recurrence Post Living Donor Liver Transplantation in End Stage Chronic HCV Patients

  2014cites this paper
• Natural History of Recurrent Hepatitis C: Impact of Immunosuppression

  2014cites this paper
• INFECTIOUS COMPLICATIONS IN LIVING DONOR TRANSPLANT RECIPIENTS Living donor liver transplantation

  2014cites this paper
• Efficacy of valganciclovir and ganciclovir for cytomegalovirus disease in solid organ transplants: A meta-analysis

  2014cites this paper
• The impact of the prevention strategies on the indirect effects of CMV infection in solid organ transplant recipients.

  2014cites this paper
• Hepatitis C virus reinfection after liver transplantation: is there a role for direct antiviral agents?

  2014cites this paper
• Infections after orthotopic liver transplantation.

  2014cites this paper
• Application of the BAR score as a predictor of short- and long-term survival in liver transplantation patients

  2014cites this paper
• Recurrent hepatitis C after liver transplant.

  2014cites this paper
• Hepatitis C virus molecular evolution: Transmission, disease progression and antiviral therapy

  2014cites this paper
• Hepatitis C virus recurrence after liver transplantation: how to treat and when.

  2014cites this paper
• INFLUENCIA DE LOS POLIMORFISMOS GENÉTICOS DE LOS RECEPTORES "TOLL-LIKE" EN LA GRAVEDAD DE LA RECIDIVA VIRAL Y EN LA INCIDENCIA DEL RECHAZO AGUDO EN PACIENTES CON TRASPLANTE HEPÁTICO POR CIRROSIS POR EL VIRUS DE LA HEPATITIS C

  2014cites this paper
• Management of cytomegalovirus infection and disease in liver transplant recipients.

  2014cites this paper
• Tratamiento de la recurrencia de la infección por VHC en pacientes trasplantados hepáticos. Optimización del proceso

  2013cites this paper
• The Hepatitis Aggressiveness Score (HAS): A Novel Classification System for Post–Liver Transplantation Recurrent Hepatitis C

  2013cites this paper
• Strategies to reduce hepatitis C virus recurrence after liver transplantation.

  2013cites this paper
• Clinical Utility of Viral Load in Management of Cytomegalovirus Infection after Solid Organ Transplantation

  2013cites this paper
• Direct Antiviral Agents for the Treatment of Hcv Reinfection after Liver

  2013cites this paper
• Viral Diseases of the Liver

  2013cites this paper
• Viral Hepatitis in Solid Organ Transplantation

  2013cites this paper
• Angiotensin blockade does not affect fibrosis progression in recurrent hepatitis C after liver transplantation.

  2013cites this paper
• Association between a functional polymorphism in Toll‐like receptor 3 and chronic hepatitis C in liver transplant recipients

  2013cites this paper
• Management of recurrent hepatitis C in orthotopic liver transplant recipients.

  2013cites this paper
• Influence of antiviral therapy in the long‐term outcome of recurrent hepatitis C virus infection following liver transplantation

  2013cites this paper
• Recurrent hepatitis C virus infection and outcome after living-donor liver transplant.

  2013cites this paper
• Prevention and Treatment of Recurrent Hepatitis C after Liver Transplantation

  2013cites this paper
• Colitis due to mycophenolate mofetil after liver transplantation: Case report

  2013cites this paper
• Treating HCV After Liver Transplantation

  2012cites this paper
• Long‐Term Management of Recurrent Primary Liver Disease

  2012cites this paper
• Cytomegalovirus Infection in Liver Transplant Recipients

  2012cites this paper
• Racial Differences in Fibrosis Progression After HCV-Related Liver Transplantation

  2012cites this paper
• Liver Transplantation and Hepatitis C

  2012cites this paper
• HCV in liver transplantation

  2012cites this paper
• Chapter 50 – Recurrent Viral Diseases after Liver Transplantation

  2012cites this paper
• Natural History of Chronic HCV After Liver Transplantation

  2012cites this paper
• Immunosuppression in hepatitis C virus-infected patients after kidney transplantation.

  2012cites this paper
• Human herpesvirus 6 in donor biopsies associated with the incidence of clinical cytomegalovirus disease and hepatitis C virus recurrence.

  2012cites this paper
• HLA tissue typing has no effect on the outcome of patients undergoing a living-donor liver transplant: a single-center experience in Egypt.

  2012cites this paper
• The association between cytomegalovirus immune globulin and long‐term recipient and graft survival following liver transplantation

  2012cites this paper
• Recurrent hepatitis C after liver transplantation.

  2012cites this paper
• Liver transplantation in the setting of chronic HCV.

  2012cites this paper
• Spanish society of liver transplantation (SETH) consensus recommendations on hepatitis C virus and liver transplantation

  2012cites this paper
• Epidemiology and risk factors of infections after solid organ transplantation.

  2012cites this paper
• Association of Cytomegalovirus Infection and Disease With Recurrent Hepatitis C After Liver Transplantation

  2012cites this paper
• Infections in the Liver Transplant Recipient

  2012cites this paper
• Liver transplantation using elderly donors: a risk factor analysis

  2011cites this paper
• GESITRA-SEIMC/REIPI recommendations for the management of cytomegalovirus infection in solid-organ transplant patients.

  2011cites this paper
• Comparative Analysis of Hepatitis C Recurrence and Fibrosis Progression Between Deceased-Donor and Living-Donor Liver Transplantation: 8-Year Longitudinal Follow-Up

  2011cites this paper
• Digital image analysis of liver collagen predicts clinical outcome of recurrent hepatitis C Virus 1 year after liver transplantation

  2011cites this paper
• Cytomegalovirus Viremia as a Risk Factor for Mortality Prior to Antiretroviral Therapy among HIV-Infected Gold Miners in South Africa

  2011cites this paper
• Cytomegalovirus ileitis in a patient after liver transplantation-differentiating from de novo IBD.

  2011cites this paper
• Severe hepatitis C virus recurrence is nearly universal after donation after cardiac death liver transplant.

  2011cites this paper
• The clinical consequences of utilizing donation after cardiac death liver grafts into hepatitis C recipients

  2011cites this paper
• Management of recurrent hepatitis C infection after liver transplantation.

  2011cites this paper
• Liver Transplantation in Patients with Hepatitis B, C or HIV Infection

  2011cites this paper
• UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE - UFCSPA PROGRAMA DE PÓS-GRADUAÇÃO EM MEDICINA: HEPATOLOGIA

  2011cites this paper
• Improving graft survival for patients undergoing liver transplantation

  2011cites this paper
• Management of viral infections in solid organ transplant recipients

  2011cites this paper
• Human cytomegalovirus infection inhibits response of chronic hepatitis‐C‐virus‐infected patients to interferon‐based therapy

  2011cites this paper
• Direct and indirect effects of cytomegalovirus: can we prevent them?

  2010cites this paper
• Cytomegalovirus infection after liver transplantation incidence, risks, and benefits of prophylaxis.

  2010cites this paper
• Hepatitis C recurrence is not adversely affected by the use of donation after cardiac death liver allografts

  2010cites this paper
• Antiviral therapy of chronic hepatitis C in patients with advanced liver disease and after liver transplantation

  2010cites this paper
• IL-2 Receptor Antagonist (Basiliximab) Is Associated with Rapid Fibrosis Progression in Patients with Recurrent Hepatitis C after Liver Transplantation Using Serial Biopsy Specimens

  2010cites this paper
• HEPATITIS Liver Stiffness Identifies Two Different Patterns of Fibrosis Progression in Patients with Hepatitis C Virus Recurrence After Liver Transplantation

  2010cites this paper